Janus Henderson Group’s Sage Therapeutics SAGE Stock Holding History

Janus Henderson Group’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,893	Closed	-$140K	–	2541
2024 Q4	$140K	Hold	25,893	–	–	﹤0.01%	2490
2024 Q3	$187K	Hold	25,893	–	–	﹤0.01%	2447
2024 Q2	$281K	Sell	25,893 -266	-1%	-$3.41K	﹤0.01%	2237
2024 Q1	$490K	Hold	26,159	–	–	﹤0.01%	2016
2023 Q4	$567K	Sell	26,159 -40	-0.2%	-$793	﹤0.01%	1931
2023 Q3	$539K	Buy	26,199 +4	+0%	+$116	﹤0.01%	1884
2023 Q2	$1.23M	Sell	26,195 -392,551	-94%	-$19.5M	﹤0.01%	1500
2023 Q1	$17.6M	Sell	418,746 -200,544	-32%	-$8.62M	0.01%	600
2022 Q4	$23.6M	Sell	619,290 -843,556	-58%	-$32.2M	0.02%	534
2022 Q3	$57.3M	Buy	1,462,846 +695,797	+91%	+$26.9M	0.02%	485
2022 Q2	$24.8M	Sell	767,049 -262,904	-26%	-$8.81M	0.02%	523
2022 Q1	$34.1M	Buy	1,029,953 +54,971	+6%	+$2.07M	0.02%	606
2021 Q4	$41.5M	Sell	974,982 -76,011	-7%	-$3.18M	0.02%	606
2021 Q3	$46.6M	Sell	1,050,993 -609,460	-37%	-$27.9M	0.02%	573
2021 Q2	$94.3M	Sell	1,660,453 -212,929	-11%	-$15.1M	0.04%	386
2021 Q1	$140M	Sell	1,873,382 -105,429	-5%	-$8.64M	0.06%	293
2020 Q4	$171M	Buy	1,978,811 +359,110	+22%	+$26.5M	0.08%	252
2020 Q3	$99M	Buy	1,619,701 +160,025	+11%	+$8.11M	0.05%	330
2020 Q2	$60.7M	Buy	1,459,676 +71,881	+5%	+$2.61M	0.03%	442
2020 Q1	$39.9M	Sell	1,387,795 -1,026,417	-43%	-$59.4M	0.03%	514
2019 Q4	$174M	Buy	2,414,212 +398,808	+20%	+$49.1M	0.09%	250
2019 Q3	$283M	Buy	2,015,404 +141,996	+8%	+$23.8M	0.15%	161
2019 Q2	$343M	Buy	1,873,408 +204,779	+12%	+$34.9M	0.19%	135
2019 Q1	$265M	Buy	1,668,629 +1,359,947	+441%	+$197M	0.15%	173
2018 Q4	$29.6M	Buy	308,682 +44,019	+17%	+$5.04M	0.02%	654
2018 Q3	$37.4M	Buy	264,663 +87,427	+49%	+$13.5M	0.02%	659
2018 Q2	$27.7M	Sell	177,236 -7,413	-4%	-$1.16M	0.02%	717
2018 Q1	$29.7M	Sell	184,649 -12,386	-6%	-$2.1M	0.02%	693
2017 Q4	$32.5M	Buy	+197,035	New	+$19.1M	0.02%	645